First‐trimester noninvasive prenatal diagnosis of seven facioscapulohumeral muscular dystrophy type 1 families using SNP ‐based amplicon sequencing: An earlier, rapid and safer way
American Journal of Medical Genetics Part A · 2024
DOI: 10.1002/ajmg.a.63560 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Medical Genetics Part A, 2024. Verfasst von Xinyu Fu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Genetic and Prenatal Diagnosis Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. Hauptthemen laut MEDLINE: Muscular Dystrophy, Facioscapulohumeral, Polymorphism, Single Nucleotide, Pregnancy Trimester, First. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Henan Province Medical Science and Technique Foundation, Henan Province Fertility Protection and Eugenics Key Laboratory Open Project, National Key Research and Development Program of China.
Abstract (Originalsprache)
The study is to explore the feasibility and value of SNP‐based noninvasive prenatal diagnosis (NIPD) for facioscapulohumeral muscular dystrophy type 1 (FSHD1) in early pregnancy weeks. We prospectively collected seven FSHD1 families, with an average gestational age of 8 +6 . Among these seven couples, there were three affected FSHD1 mothers and four affected fathers. A multiplex‐PCR panel comprising 402 amplicons was designed to selective enrich for highly heterozygous SNPs upstream of the DUX4 gene. Risk haplotype was constructed based on familial linkage analysis. Fetal genotypes were accurately inferred through relative haplotype dosage analysis using Bayes Factor. All tests were successfully completed in a single attempt, and no recombination events were detected. NIPD results were provided within a week, which is 4 weeks earlier than karyomapping and 7 weeks earlier than Bionano single‐molecule optical mapping (BOM). Ultimately, five FSHD1 fetuses and two normal fetuses were successfully identified, with a 100% concordance rate with karyomapping and BOM. Therefore, SNP‐based NIPD for FSHD1 was demonstrated to be feasible and accurate in early weeks of gestation, although the risk of recombination events cannot be completely eliminated. In the future, testing of more cases is still necessary to fully determine the clinical utility.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Genetic and Prenatal Diagnosis Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
- Department of Fetal Medicine & Prenatal Diagnosis Center, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai, China.
- Celula (China) Medical Technology Co., Ltd., Chengdu, China.
ORCID-Profile: Xiangdong Kong
Förderung
- Henan Province Medical Science and Technique Foundation
- Henan Province Fertility Protection and Eugenics Key Laboratory Open Project
- National Key Research and Development Program of China
- Henan Province Medical Science and technology project (joint construction)
Zitieren
APA
Fu, X., Zhao, Z., Kong, L., Li, S., Li, F., Han, X., Sun, L., Wu, D., Wang, Y., & Kong, X. (2024). First‐trimester noninvasive prenatal diagnosis of seven facioscapulohumeral muscular dystrophy type 1 families using SNP ‐based amplicon sequencing: An earlier, rapid and safer way. American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmg.a.63560
Vancouver
Fu X, Zhao Z, Kong L, Li S, Li F, Han X, et al. First‐trimester noninvasive prenatal diagnosis of seven facioscapulohumeral muscular dystrophy type 1 families using SNP ‐based amplicon sequencing: An earlier, rapid and safer way. American Journal of Medical Genetics Part A. 2024. doi:10.1002/ajmg.a.63560
BibTeX
@article{Fu2024,
author = {Fu, Xinyu and Zhao, Zhenhua and Kong, Lingrong and Li, Shaojun and Li, Feifei and Han, Xiujuan and Sun, Luming and Wu, Di and Wang, Yanan and Kong, Xiangdong},
title = {First‐trimester noninvasive prenatal diagnosis of seven facioscapulohumeral muscular dystrophy type 1 families using SNP ‐based amplicon sequencing: An earlier, rapid and safer way},
journal = {American Journal of Medical Genetics Part A},
year = {2024},
doi = {10.1002/ajmg.a.63560}
}
EUVIMED